Your browser version may not work well with NCBI's Web applications. More information here...
1: Clin Biochem. 2007 Apr;40(7):447-53. Epub 2007 Jan 13.Click here to read Links

Inter- and intra-individual variations in normal urinary glycine betaine excretion.

Clinical Biochemistry Unit, Canterbury Health Laboratories, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand. michael.lever@chmeds.ac.nz

OBJECTIVES: To establish whether normal human subjects excrete glycine betaine at a constant rate. DESIGN AND METHODS: Urine was collected from ten normal healthy male subjects for 14 days, during which fluid intake was systematically varied from <800 mL to >3 L per day. Glycine betaine, sorbitol and creatinine excretions were estimated per day and as millimole per mol creatinine. RESULTS: The intrasubject SD of urine glycine betaine was 3.5 mmol/mol creatinine, and the intersubject SD 5.8 mmol/mol creatinine. The intrasubject SD of plasma glycine betaine was 10.2 mol/L and the intersubject SD 14.2 mol/L. Water load had little effect on glycine betaine excretion and plasma glycine betaine. After 12 years, excretions and plasma concentrations tended to parallel the initial results. CONCLUSIONS: Normal subjects have consistent individual glycine betaine excretions that are not strongly influenced by urine volume. Abnormal excretions, or significant changes in excretion, can be interpreted as indicating a pathological process.

PMID: 17335790 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Betaine (Cystadane® )

    Betaine is used to treat homocystinuria (an inherited condition in which the body cannot break down a certain protein, causing build-up of homocysteine in the blood). Increased amounts of homocysteine in the body can cau...